24 December 2022 : Clinical Research
Single-Center Study in Lithuania to Evaluate the Role of Transthoracic Impedance Cardiography in the Diagnosis and Outcome Evaluation of 301 Patients with Chronic Heart Failure Exacerbation
Andrius Ališauskas1ABCDEFG*, Albinas Naudžiūnas1ACDEFG, Saulius Sadauskas 1ABCDEF, Laima Jankauskienė1ACDE, Eglė Kalinauskienė1ACDE, Giedrė Vanagaitė2BCDEDOI: 10.12659/MSM.938389
Med Sci Monit 2022; 28:e938389
Table 1 Main characteristics of the studied patients.
Variable | Mean±95% CI |
---|---|
Gender (M/F) | 166/135 |
Age (years) | 71.87±6.74 |
Heart rate (bpm) | 79.03±2.5 |
sBP (mmHg) | 132.95±2.95 |
dBP (mmHg) | 80.33±1.8 |
RR (breaths/minute) | 16.75±0.231 |
SpO (%) | 94.71±0.552 |
NYHA class | 3.09±0.0624 |
6MWD (meters) | 271.32±11.7 |
LVEF (%) | 36.04±1.76 |
LVDd (millimeters) | 50.606±1.09 |
LAD (millimeters) | 49.25±1.08 |
NT-proBNP (pmoL/L) | 283.9±22.58 |
Serum creatinine level (μmoL/L) | 111.003±5.09 |
Bed days | 24.66±0.732 |
Readmissions (at 6 months) | 1.3±0.09 |
Readmissions (at 12 months) | 1.99±0.15 |
Coronary artery disease | 60 |
Arterial hypertension | 23 |
Arrhythmias | 10 |
Valvular heart disease | 7 |
sBP – systolic blood pressure; dBP – diastolic blood pressure; RR – respiratory rate; SpO – noninvasively measured oxygen saturation; NYHA – New York Heart Association; 6MWD – 6-min walk distance; LVEF – left ventricular ejection fraction; LVDd – left ventricular end-diastolic dimension; LAD – left atrial dimension; NT-proBNP – amino-terminal pro-brain natriuretic peptide. |